🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

California fertility clinic sued for using embryo with deadly cancer gene

Published 03/01/2023, 01:38 PM
Updated 03/01/2023, 05:46 PM
© Reuters.

By Brendan Pierson

(Reuters) -A California couple sued a Pasadena-based fertility clinic on Wednesday, saying it allegedly implanted an embryo carrying a rare gene that causes deadly stomach cancer and then falsified records to cover up its mistake.

In their lawsuit against HRC Fertility, filed in Los Angeles Superior Court, Jason and Melissa Diaz said their son, now a year old, will require total stomach removal surgery as a young adult to prevent or treat the cancer. They said they went to HRC Fertility specifically to avoid having a child with the gene, which Jason carries.

Jason had total stomach removal in 2018 after developing the rare cancer, known as hereditary diffuse gastric cancer, and two of his aunts died of stomach cancer in their 40s, according to the lawsuit, which also names the HRC doctor who worked with the couple, Bradford Kolb, as a defendant.

"We went to HRC Fertility to break the family curse of cancer and early death," he said in a statement. "Trusting Dr. Kolb and HRC turned out to be the biggest mistake of our lives."

Melissa Diaz in 2020 had her eggs retrieved. Those eggs were fertilized with Jason's sperm to create embryos to be implanted, a process known as in vitro fertilization or IVF.

All of the embryos were tested for the cancer gene. Kolb transferred one embryo without the gene in 2020, but that pregnancy ended in a miscarriage, according to the lawsuit.

An HRC employee then told Melissa that they had another embryo without the gene, and she responded that the couple wanted to transfer that embryo. In fact, the employee was wrong and the embryo did carry the gene, the lawsuit said.

In January 2021, Kolb transferred the embryo. The Diazes said they did not learn that their son carried the gene until after he was born that September, when they saw it mentioned in handwritten notes on a report of the January 2021 transfer.

Melissa then requested her medical records, and HRC produced a "falsified" version with the handwritten notes removed, according to the lawsuit.

© Reuters. Illustrative: A medical technician prepares embryo and sperm samples for freezing in Paris, France, September 19, 2019. REUTERS/Benoit Tessier

"We deeply empathize with this family's situation," HRC said in a statement, adding that the Diazes "wished to have a male embryo transferred, which we carried out according to the family's explicit wishes and in accordance with the highest level of care."

The company did not further address the allegations in the lawsuit.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.